Cell Therapy

Cell Therapy

Recently Added |View More

Improved Stem Cell Transplant Outcomes Achieved at Roswell Park; Named Optum Center of Excellence News

Improved Stem Cell Transplant Outcomes Achieved at Roswell Park; Named Optum Center of Excellence

Optum, a national health service leader, has once again recognized Roswell Park Comprehensive Cancer Center as a Center of Excellence for both pediatric and adult stem cell transplant programs.

“New Era for Transplants”: Roswell Park Reports Increased Survival Outcomes One Year Following Allogeneic Transplant Video

“New Era for Transplants”: Roswell Park Reports Increased Survival Outcomes One Year Following Allogeneic Transplant

A new era in transplantation is here. Roswell Park reports a remarkable 92.6% one-year survival rate following allogeneic transplant—well above the national average—thanks to evidence-based innovations transforming patient care.

Join Roswell Park Experts at ASCO News

Join Roswell Park Experts at ASCO

Nearly two dozen experts from Roswell Park Comprehensive Cancer Center will be attending this year’s American Society of Clinical Oncology conference in Chicago, May 30-June 3, and we’d like to invite you to meet them.

Roswell Park Faculty to Present at National Comprehensive Cancer Network 2026 Annual Conference News

Roswell Park Faculty to Present at National Comprehensive Cancer Network 2026 Annual Conference

Clinical researchers from Roswell Park Comprehensive Cancer Center are among the experts invited to share insights and clinical best practices at the National Comprehensive Cancer Network (NCCN) 2026 Annual Conference March 27-29 in Orlando, Florida.

Roswell Park Offering CAR T Trial for Autoimmune Conditions Video

Roswell Park Offering CAR T Trial for Autoimmune Conditions

While most CAR T-cell therapies and clinical trials are directed at cancers, a new phase 1 trial at Roswell Park Comprehensive Cancer Center is open and recruiting patients with a variety of autoimmune conditions.

Roswell Park Offers Exclusive CAR T-Cell Clinical Trial for Patients with Advanced or Metastatic Hepatoma Video

Roswell Park Offers Exclusive CAR T-Cell Clinical Trial for Patients with Advanced or Metastatic Hepatoma

 A new, first-in-humans clinical trial for hepatocellular carcinoma uses an “armored” CAR T-cell therapy designed to resist the hostile tumor microenvironment found in 77% of patients with this disease.

This site is intended for healthcare professionals

RPMD App
Access wherever you go

Click your preferred app store below to download our free mobile app — exclusively for physicians and physician offices — for direct access to a complete, up-to-date directory of Roswell Park physicians wherever you go. Email or call to refer a patient or ask a question with a click of a button.